Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jan 4, 2026

Electrophysiological Measurements and Analysis of Nociception in Human Infants

Electrophysiological Measurements and Analysis of Nociception in Human Infants

Published on: December 20, 2011

Response to R. Jayaraj

Etienne Dauzier¹, Benjamin Lacas¹, Pierre Blanchard²

¹Meta-Analysis Unit, Service de Biostatistique et d'Epidémiologie, Gustave Roussy Cancer Campus, INSERM U1018, CESP, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.

|November 6, 2019

Summary

No abstract available in PubMed .

Keywords:

Chemotherapy Head and neck cancer Heterogeneity Individual patient data Meta-analysis Randomized trial Squamous cell carcinoma Surgery

More Related Videos

Modified Drop Tower Impact Tests for American Football Helmets

Modified Drop Tower Impact Tests for American Football Helmets

Published on: February 19, 2017

Cryo-EM and Single-Particle Analysis with Scipion

Cryo-EM and Single-Particle Analysis with Scipion

Published on: May 29, 2021

Related Experiment Videos

Last Updated: Jan 4, 2026

Electrophysiological Measurements and Analysis of Nociception in Human Infants

Electrophysiological Measurements and Analysis of Nociception in Human Infants

Published on: December 20, 2011

Modified Drop Tower Impact Tests for American Football Helmets

Modified Drop Tower Impact Tests for American Football Helmets

Published on: February 19, 2017

Cryo-EM and Single-Particle Analysis with Scipion

Cryo-EM and Single-Particle Analysis with Scipion

Published on: May 29, 2021

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cost-Utility Analysis Alongside the GORTEC 2014-01 TPExtreme trial - Author Response to Letter to the Editor.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Same author

Risk factor analysis of 115 children and adolescents with primary mediastinal B-cell lymphoma treated with DA-EPOCH-R.

Blood advances·2026

Same author

Hypofractionated split-course versus standard radiotherapy in frail older patients with head and neck squamous-cell carcinoma (ELAN-RT trial): a non-inferiority, multicentre, open-label, randomised controlled trial.

The lancet. Healthy longevity·2026

Same author

Induction Nivolumab Before Chemoradiation in High-Risk Human Papillomavirus-Driven Oropharynx Cancers: IMMUNEBOOST-HPV, a Multicenter Randomized Phase II Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Same author

Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2025

Same author

Cost-Utility Analysis Alongside the GORTEC 2014-01 TPExtreme Trial: TPEx Versus EXTREME as First-Line Treatment in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2025